BioSpace News Archive

Business

Bicycle Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Bicycle Therapeutics plc today reported financial results for the fourth quarter and full year ended December 31, 2022, and provided recent corporate updates.

February 28, 2023

·

10 min read

FDA

Touchlight Announces First FDA Clearance of an IND Utilising Doggybone DNA

Touchlight, a CDMO pioneering enzymatic DNA production to enable genetic medicines, today announced the first FDA clearance of an Investigational New Drug (IND) application in the US utilising doggybone DNA (dbDNA™).

February 28, 2023

·

2 min read

NeoGenomics to Present at the 44th Annual Raymond James Institutional Investors Conference

NeoGenomics, Inc. today announced that Chris Smith, chief executive officer of NeoGenomics, and Jeff Sherman, chief financial officer, will participate in a fireside chat at the 44th Annual Raymond James Institutional Investors Conference on Monday, March 6, 2023 at 7:30am ET.

February 28, 2023

·

3 min read

Lone Star Bio

Enzolytics, Inc. Highlights Plans for Promotion of IPF Immune(TM), Its Patented Nutraceutical Supplement

Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ). Enzolytics, Inc. has completed the onboarding process on Amazon ( www.amazon.com ) for its IPF Immune nutritional supplement, permitting the direct sale and distribution of IPF Immune through the Amazon platform.

February 28, 2023

·

5 min read

Bio NC

Syneos Health Unveils New Decentralized Clinical Trial Site Network to Drive DCT Adoption

Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, announced the launch of a Decentralized Clinical Trial Site Network to drive appropriate DCT adoption and enable high quality delivery of DCTs and digital health technology solutions.

February 28, 2023

·

3 min read

Drug Development

Incyclix Bio Announces FDA Clearance of Investigational New Drug Application for INX-315 in Patients with Advanced or Metastatic Cancer

Incyclix Bio, LLC today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for the Company’s lead compound, INX-315, a novel, potent and selective CDK2 inhibitor.

February 28, 2023

·

2 min read

Business

Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment

Sunshine Biopharma Inc. today announced the signing of an exclusive worldwide license agreement (the “License Agreement”) with the University of Arizona.

February 28, 2023

·

4 min read

Business

Theratechnologies Reports Financial Results and Business Updates for the Fourth Quarter and Full Year Fiscal 2022

Theratechnologies Inc. today reported business highlights and financial results for the fourth quarter and full year ended November 30, 2022. All figures are in U.S. dollars unless otherwise stated.

February 28, 2023

·

31 min read

Drug Development

Factor Bioscience Announces Publication of Preclinical Results of Aerosolized mRNA For the Treatment of Pneumonia

Factor Bioscience Inc. announced the results of preclinical testing of aerosolized mRNA formulations currently under development for the treatment of pneumonia-associated lung inflammation.

February 28, 2023

·

3 min read

Business

Korro Bio Appoints Dr. Steve Colletti as Chief Scientific Officer

Korro Bio, Inc ., a leading RNA editing company focused on the discovery and development of novel genetic medicines, today announced the appointment of Steve Colletti, Ph.D. as Chief Scientific Officer.

February 28, 2023

·

3 min read